4.1 Letter

Failed Response to Repeat Intravenous Ketamine Infusions in Geriatric Patients With Major Depressive Disorder

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Ketamine as a Novel Antidepressant: From Synapse to Behavior

J. W. Murrough

CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)

Article Neurosciences

Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression

Marije aan het Rot et al.

BIOLOGICAL PSYCHIATRY (2010)

Article Clinical Neurology

The Use of a Series of Ketamine Infusions in Two Patients With Treatment-Resistant Depression

M. Messer et al.

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2010)

Article Clinical Neurology

Late- versus early-onset geriatric depression in a memory research center

Carol Dillon

Neuropsychiatric Disease and Treatment (2010)

Article Psychiatry

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

Carlos A. Zarate et al.

ARCHIVES OF GENERAL PSYCHIATRY (2006)

Article Neurosciences

Antidepressant effects of ketamine in depressed patients

RM Berman et al.

BIOLOGICAL PSYCHIATRY (2000)

Article Geriatrics & Gerontology

Changes in anesthetic sensitivity and glutamate receptors in the aging canine brain

KR Magnusson et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2000)